Cargando…
Oncotype DX Breast Cancer recurrence score resists inter-assay reproducibility with RT(2)-Profiler Multiplex RT-PCR
The Oncotype Dx assay is frequently used to test if breast cancer patients can be spared from chemotherapy without negative effects for their future clinical course. However, due to conflicting data on the assay utility, in the recent past its reimbursement situation in Germany was revised; due to c...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937305/ https://www.ncbi.nlm.nih.gov/pubmed/31889145 http://dx.doi.org/10.1038/s41598-019-56910-0 |